PDLIM4 Antibody

Western Blot: PDLIM4 Antibody [NBP1-80833]

Western Blot: PDLIM4 Antibody [NBP1-80833] - Lane 1: NIH-3T3 cell lysate (Mouse embryonic fibroblast cells). Lane 2: NBT-II cell lysate (Rat Wistar bladder tumor cells).

Western Blot: PDLIM4 Antibody [NBP1-80833]

Western Blot: PDLIM4 Antibody [NBP1-80833] - Analysis in human cell line RH-30.

Immunohistochemistry-Paraffin: PDLIM4 Antibody [NBP1-80833]

Immunohistochemistry-Paraffin: PDLIM4 Antibody [NBP1-80833] - Staining of human Fallopian tube shows weak to moderate membranous and cytoplasmic positivity in glandular cells.

Immunohistochemistry-Paraffin: PDLIM4 Antibody [NBP1-80833]

Immunohistochemistry-Paraffin: PDLIM4 Antibody [NBP1-80833] - Staining of human kidney shows weak to moderate cytoplasmic positivity in cells in tubules.

Western Blot: PDLIM4 Antibody [NBP1-80833] -

Western Blot: PDLIM4 Antibody [NBP1-80833] - SH-I-14 reduces the in vivo growth of tumors in xenograft mice bearing tumors of MDA-MB-231 cellsA. SH-I-14 (10 mg/kg) or DMSO was injected into peritoneal cavity of mouse with MDA-MB-231 tumors three times per week from 8-days after tumor cell injection. The control mice were euthanized earlier due to large tumor size. Tumor volumes were measured as described in Materials & Methods. Data are shown as mean±SD. **P < 0.01. B. SH-I-14 reduces acetyl-STAT3 & induces the expression of VHL & PDLIM4 protein in vivo. The MDA-MB-231 xenograft mice (3 mice per group) were administered with 10 mg/kg of SH-I-14 daily for 5 days & lysates from each tumor were subjected to western blot analysis as indicated. beta-actin was used as a loading control. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/29137356), licensed under a CC-BY license. Not internally tested by Novus Biologicals.